Navigation Links
Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2011 Results
Date:1/21/2011

GLENWOOD, Ill., Jan. 21, 2011 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal first quarter of 2011 pre-market on Tuesday, February 1, 2011.

The company will host a conference call for investors on Tuesday, February 1, 2011, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 877-941-2928 (within the United States and Canada), or 480-629-9726 (international callers), or by visiting the "Investors" page on the company's website at www.landauerinc.com. Please log on to the website at least 15 minutes early to register, download and install any necessary audio software.

Investors may access a replay of the call by dialing 800-406-7325 (within the United States and Canada), or 303-590-3030 (international callers), passcode 4404862#, which will be available through Tuesday, March 1, 2011. The replay will also be available on Landauer's website for 90 days following the call.

About Landauer

Landauer is the world's leading provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The Company provides its dosimetry services to approximately 1.6 million people globally. In addition, through its Global Physics Solutions subsidiary, the Company provides
'/>"/>

SOURCE Landauer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Landauer, Inc. Declares Regular Cash Dividend
2. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2010 Results
3. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results
4. Lilly Confirms Date and Conference Call for Fourth-Quarter and Full-Year 2010 Financial Results Announcement
5. VirtualScopics Schedules Third Quarter 2010 Earnings Announcement
6. Lilly Confirms Date and Conference Call for Third-Quarter 2010 Financial Results Announcement
7. Perrigo Confirms Filing for Omeprazole/Sodium Bicarbonate and Announcement of Patent Infringement Lawsuit by Schering-Plough Healthcare Products
8. Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
9. Arthritis Foundation and Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign, Urging People Living With Gout to Keep Enjoying Lifes Simple Pleasures
10. Perrigo Confirms Filing for Clobetasol Shampoo and Announcement of Patent Infringement Lawsuit by Galderma
11. Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... YORK , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ...
(Date:1/15/2014)... R.I. , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... Oct. 27 According to Millennium Research Group ... intelligence, the European arthroscope market generated over $30 ... over 2009 due to decreasing scope prices and ... Due to unfavorable economic conditions, manufacturers are ...
... today announced that it has received approval from the ... (US 7,815,929) regarding a method for the preparation, storage ... very nature, the process of compounding suppositories is cumbersome, ... Indu Muni, founder, chairman, and CEO of CutisPharma, Inc. ...
Cached Medicine Technology:Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010 2Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010 3CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding 2
(Date:4/17/2014)... presence of chronic inflammation in benign prostate tissue ... and this association was found even in those ... a study published in Cancer Epidemiology, Biomarkers ... Association for Cancer Research. , An analysis of ... the placebo arm of the Prostate Cancer Prevention ...
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... recent papers by a University of Colorado School ... develop treatments or vaccines for Dengue fever, West ... disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, associate ... School of Medicine and an early career scientist ... recently published articles in the scholarly journals ...
(Date:4/17/2014)... military personnel who served in Iraq and Afghanistan ... injury (TBI) were compared to military personnel without ... Differences in measures of overall disability, cognitive function, ... are reported in an article in Journal ... Ann Liebert, Inc., publishers. The article is available ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... One of the largest individual studies of the effects of ... it makes no difference whether a woman drinks wine, beer ... alcohol) and the quantity consumed that is likely to trigger ... drinking three or more alcoholic drinks a day is similar ...
... today that Sanofi-Aventis has renewed its licenses ... Analysis Pipeline., The pipeline provides a fully ... of expression and tiling microarray experiments, including ... software module ChipInspector seamlessly integrates with additional ...
... liquor present same risk, OAKLAND, Calif., Sept. 27 ... of alcohol on the risk of breast cancer shows ... beer or spirits,(liquor). It is the alcohol itself (ethyl ... In fact, the increased breast,cancer risk from drinking three ...
... Acquisition to Expand Thomson Scientific,s Market-leading Portfolio of ... Chemistry and Drug Discovery Information Solutions, STAMFORD, Conn., ... TSX: TOC), a leading provider of information,solutions to business ... Prous Science, a global leader in the provision of,life ...
... Albemarle,Corporation (NYSE: ALB ), a global ... the price of its Ibuprofen 40 micron,and Ibuprofen ... Ibuprofen 20 micron,product by 20 percent, worldwide, effective ... http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO ) "Albemarle proudly stands ...
... In a letter,sent today to California Assembly Speaker ... Consumer Rights (FTCR) urged their,opposition to any health care ... Gov. Arnold Schwarzenegger and Assembly Speaker Fabian Nunez ... care reform that will require every,Californian to prove they ...
Cached Medicine News:Health News:Wine, women and... spirits, beer and breast cancer risk 2Health News:Wine, women and... spirits, beer and breast cancer risk 3Health News:Kaiser Permanente Study Shows Alcohol Consumption - No Matter Beverage Type - Linked to Breast Cancer Risk 2Health News:Kaiser Permanente Study Shows Alcohol Consumption - No Matter Beverage Type - Linked to Breast Cancer Risk 3Health News:Kaiser Permanente Study Shows Alcohol Consumption - No Matter Beverage Type - Linked to Breast Cancer Risk 4Health News:Thomson Acquires Prous Science 2Health News:Thomson Acquires Prous Science 3Health News:Thomson Acquires Prous Science 4Health News:Albemarle to Increase Price of Ibuprofen 2Health News:Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance 2Health News:Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance 3Health News:Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance 4Health News:Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance 5Health News:Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance 6Health News:Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance 7Health News:Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance 8Health News:Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance 9Health News:Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance 10
Open 14 mm blades with 6 mm lifting wings. Dull finish....
Solid 6 mm solid blade speculum for newborn or pediatric use....
Angled for temporal approach. Wire 14 mm rounded blades for patient comfort. Dull finish....
Open wire style 16 mm blade with a wing tip twist giving the surgeon better on-axis accessibility....
Medicine Products: